<DOC>
	<DOCNO>NCT01313845</DOCNO>
	<brief_summary>A double-blinded randomized placebo-controlled trial intravenous amantadine gait freeze refractory oral anti-parkinsonian medication patient Parkinson 's disease . - administration IV amantadine normal saline 5 day , 2 time day keep current oral anti-parkinsonian medication unchanged - follow-up administration IV amantadine 4 week - allocation ratio amantadine : normal saline 2:1</brief_summary>
	<brief_title>Effect Intravenous Amantadine Gait Freezing Parkinson 's Disease</brief_title>
	<detailed_description>Intravenous amantadine know effective parkinsonian motor symptom abruptly aggravate disable motor symptom severe motor fluctuation dyskinesia patient Parkinson 's disease . The study investigator experience several open label case benefit intravenous amantadine parkinsonian motor symptom freeze gait well . In addition , pilot open label trial parkinsonian patient refractory freeze gait show marked benefit patient Parkinson 's disease , patient parkinson-plus syndrome . This study aim evaluate efficacy intravenous amantadine levodopa-unresponsive freezing gait disable state freezing gait patient Parkinson 's disease .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<criteria>diagnosis Parkinson 's disease accord United Kingdom Parkinson 's Disease Brain Bank criterion presence freeze gait score Freezing Gait Questionnaire 7 treat oral dopamine replacement therapy 6 month score Korean version minimental status examination 20 presence significant cognitive dysfunction , behavioral psychiatric disorder presence severe cardiac disease presence renal failure , seizure , peptic ulcer disease , liver disease , pheochromocytoma , chronic exhaustive disease , malignancy participation clinical trial within 4 week pregnancy lactate woman hypersensitivity study drug history intoxication heavy metal</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>